Innovating Works

STAB VIDA INVESTIGACAO E SERVICOS EM CIE...

DIRNANO: Directing the immune response through designed nanomaterials STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA participó en un H2020: H2020-MSCA-ITN-2020 DIRNANO provides a highly integrated and interdisciplinary training of next-generation Early Stage Researchers (ESRs) at the interface of na...
2020-08-31 - 2024-09-30 | Financiado
LungCARD: Blood test for clinical therapy guidance of non small cell lung cancer patients STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA tramitó un H2020: H2020-MSCA-RISE-2016 Lung cancer is the most common cancer worldwide. NSCLC alone make up about 75% of all lung cancers and most hospitals currently test all NSC...
2016-12-02 - 2022-10-31 | Financiado
PANA: PROMOTING ACTIVE AGEING FUNCTIONAL NANOSTRUCTURES FOR ALZHEIMER S DISEASE AT ULTRA EARLY STAGES. STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA participó en un H2020: H2020-NMP-2014-2015 Alzheimer’s disease (AD) is the leading cause of dementia and loss of autonomy in the elderly, implying a progressive cognitive decline and...
2016-03-04 - 2021-08-31 | Financiado
easierNGS: CERTIFIED PACKS FOR EASIER NEXT GENERATION SEQUENCING CLINICAL DIAGNOSTICS STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA tramitó un H2020: H2020-SMEInst-2014-2015 Next-generation sequencing (NGS) has revolutionized genomic research by drastically decreasing the cost of sequencing and increasing the thr...
2014-09-03 - 2015-02-28 | Financiado
LungCARD: Point of care blood device for fast and reliable prediction of drug response in non small cell lung... STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA tramitó un FP7: Chemotherapy is the standard care for the treatment of non-small cell lung carcinoma (NSCLC) patients, however most of non-small cell lung c...
Financiado
AU-NANOPROBES FOR TB: Disposable Point of Care DNA kit for Mycobacterium tuberculosis STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA tramitó un FP7: Tuberculosis Bacillus (TB) and poverty come together to perpetuate a vicious cycle. Poverty contributes to the spread of TB as people are fo...
Financiado
HILYSENS II: Demonstration Activities for the clinical validation of the prototype HILYSENS Lab on a Chip STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA tramitó un FP7: HILYSENS II is based on the 2-year HILYSENS research and development project (started November 2010) funded by the ‘Research for the Benefit...
Financiado
NAD: NANOPARTICLES FOR THERAPY AND DIAGNOSIS OF ALZHEIMER DISEASE STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA participó en un FP7: The search for effective therapies and early detection strategies for Alzheimer’s Disease (AD), the major cause of dementia in Europe, is im...
Financiado
EXTRABRAIN: Extracellular brain proteolysis in neuronal plasticity and neuropsychiatric disorders STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA participó en un FP7: Brain disorders comprise a major burden for the society. Recent analyses of the neuropsychiatric disease-related gene polymorphisms as well...
Financiado
HILYSENS: Highly sensitive and specific low cost lab on a chip system for Lyme disease diagnosis STAB VIDA INVESTIGACAO E SERVICOS EM CIENCIAS BIOLOGICAS LDA participó en un FP7: The aim of HILYSENS is to develop a novel lab-on-chip diagnostic tool to improve clinical diagnostic, disease monitoring and treatment of Ly...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.